Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tecan Shows Ongoing Commitment to Clinical and Research Markets in China

Published: Monday, June 24, 2013
Last Updated: Monday, June 24, 2013
Bookmark and Share
Key opinion leaders from major hospital clinical laboratories in China recently visited Tecan’s European research and development centers.

The two-day program included a series of presentations and interactive workshops – as well as tours of Tecan’s research and manufacturing facilities in both Männedorf, Switzerland, and Grödig, Austria – and was intended to help guide the future development of Tecan laboratory automation solutions for this fast-growing market.

The visit began at Tecan’s global headquarters on the shores of Lake Zurich, with a presentation and demonstration of a Freedom EVO workstation configured for ELISA processing. This system, developed as part of an ongoing collaboration with hospitals and blood centers across China, introduces a number of unique features designed specifically to meet the requirements of the Chinese clinical market. The latest developments for this exciting project include a number of options to increase throughput and ease-of-use, such as a Chinese language version of the recently released TouchTools™ 3.0 touchscreen user interface. Sample and process security has been further enhanced with the addition of Tecan’s unique QC Kit, which provides liquid handling performance verification and reporting to comply with stringent regulations. Visitors were also given the opportunity to outline their current hospital laboratory practices and likely future requirements, helping to ensure that future clinical solutions are tailored to the exact needs of end-users.

The Austrian leg of the tour included presentation of a number of detection solutions to meet various aspects of clinical and research laboratory workflows, as well as interactive workshops to help shape future development of detection instruments and software for the Asian research market. Customers were introduced to a number of solutions from Tecan’s detection portfolio, including cost-effective instruments for routine ELISA processing – such as the Infinite F50 ELISA reader and Sunrise™ absorbance reader – and state-of-the-art multimode readers, such as the Infinite M1000 PRO. Delegates were given a demonstration of the Infinite M1000 PRO’s advanced assay development capabilities, combining premium Quad4 Monochromators™ optics with a range of advanced software features – such as luminescence scanning capabilities – to provide unlimited flexibility in assay design. The versatility of the Infinite M200 PRO was also highlighted during the visit, showcasing both the unrivalled cell-based assay performance of the system’s Gas Control Module (GCM™) and the low volume DNA quantification capabilities of Tecan’s unique NanoQuant Plate™. The trip was rounded off with a brief introduction to some of the vibrant history and culture of both Salzburg and Vienna, giving delegates a chance to take a mix of fond memories and innovative ideas back to their own laboratories.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Phenomenex,Tecan Partner
Phenomenex, Inc. and the Tecan Group has announced a collaboration to co-market automated solid phase extraction (SPE) sample preparation solutions.
Wednesday, September 09, 2015
Too Gracious a Host
Scientists at the University of Toronto are using Tecan’s Infinite M200 PRO and Gas Control Module to study host-pathogen interactions for Legionella bacteria.
Monday, October 07, 2013
Investigating Protein Targets and Cellular Pathways in Yeasts
Scientists at the Donnelly Centre for Cellular and Biomolecular Research have chosen generations of Tecan microplate readers to monitor the effects of environmental or drug perturbation on molecularly barcoded yeasts.
Monday, October 07, 2013
Reprogramming Nature
Researchers in the Synthetic Biology Center at the Massachusetts Institute of Technology are using a Freedom EVO® workstation to aid the development of genetic circuits.
Monday, October 07, 2013
A Watchful Eye on Biosecurity
Intended for government laboratory and pharmaceutical screening applications, BioSentinel now recommends the Infinite F500 to all its customers.
Monday, October 07, 2013
The Tecan-Fudan University Demo Lab opens in Shanghai
Tecan and Fudan University in Shanghai have joined forces to open a demonstration laboratory in the University’s School of Pharmacy.
Monday, June 24, 2013
Joining the Digital Age
TES Pharma has recently purchased an HP D300 Digital Dispenser, and is now reaping the benefits of direct titration with improved assay reproducibility and more time to perform exploratory research.
Thursday, February 21, 2013
Boston Plays Host to the Fifth Tecan Symposium
This year’s symposium explored the topic of ‘Mass spectrometry - the expanding role in life sciences and diagnostics.’
Wednesday, December 12, 2012
Tecan and Reinnervate Team up for Automation of 3D Cell Culture
Alvetex Scaffold for the automation of 3D cell culture.
Tuesday, June 26, 2012
Tecan Collaborates with China to Embrace a Whole New Dimension in Blood Safety
Tecan is working with the Chinese Society of Blood Transfusion in a bid to steadily improve both the capabilities and the quality of blood screening services.
Tuesday, May 22, 2012
Tecan and Attana Extend Distribution Agreement
Tecan to distribute Attana's label-free biosensor instruments and QCM assay technology in Europe.
Friday, October 14, 2011
Tecan and Covaris co-market Freedom EVO® with Adaptive Focused Acoustics™
The joint offering will be available to customers for sample preparation, compound management and next generation sequencing applications.
Friday, November 19, 2010
Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
New solution combines multiplexing and automation technologies to create novel system for newborn screening laboratories.
Friday, October 15, 2010
Tecan Automated Solutions Accelerate Crop Improvement
University of Kiel scientists use Tecan Freedom EVO® for the development of TILLING® programs for rape seed and sugar beet.
Friday, July 16, 2010
Tecan Provides Automated Solutions for Molecular Pharmacology
Leibniz-Institut uses Tecan’s Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries.
Tuesday, July 06, 2010
Scientific News
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH has announced that decipher the genome of the blacklegged tick which could lead to new tick control methods.
"Dark Side" of the Transcriptome
New approach to quantifying gene "read-outs" reveals important variations in protein synthesis and has implications for understanding neurodegenerative diseases.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
'Molecular Movie' Opens Door to New Cancer Treatments
An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.
New Source of Mutations in Cancer
Recently, a new mutation signature found in cancer cells was suspected to have been created by a family of enzymes found in human cells called the APOBEC3 family.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Madison Researchers Begin Work on Zika Virus
Work will start with basic questions about Zika virus infection.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!